Literature DB >> 32295416

Novel Indices of Coronary Physiology: Do We Need Alternatives to Fractional Flow Reserve?

Giovanni Luigi De Maria1, Hector M Garcia-Garcia2, Roberto Scarsini1, Alexandre Hideo-Kajita2, Nieves Gonzalo López3, Antonio Maria Leone4, Giovanna Sarno5, Joost Daemen6, Evan Shlofmitz2, Allen Jeremias7, Matteo Tebaldi8, Hiram Grando Bezerra9, Shengxian Tu10, Pedro A Lemos11,12, Yuichi Ozaki2, Kazuhiro Dan2, Carlos Collet13, Adrian P Banning1, Emanuele Barbato14, Nils P Johnson15, Ron Waksman2.   

Abstract

Fractional flow reserve is the current invasive gold standard for assessing the ischemic potential of an angiographically intermediate coronary stenosis. Procedural cost and time, the need for coronary vessel instrumentation, and the need to administer adenosine to achieve maximal hyperemia remain integral components of invasive fractional flow reserve. The number of new alternatives to fractional flow reserve has proliferated over the last ten years using techniques ranging from alternative pressure wire metrics to anatomic simulation via angiography or intravascular imaging. This review article provides a critical description of the currently available or under-development alternatives to fractional flow reserve with a special focus on the available evidence, pros, and cons for each with a view towards their clinical application in the near future for the functional assessment of coronary artery disease.

Entities:  

Keywords:  angiography; computed tomography; coronary artery disease; fractional flow reserve; hyperemia; intravascular imaging

Year:  2020        PMID: 32295416     DOI: 10.1161/CIRCINTERVENTIONS.119.008487

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  7 in total

1.  Impact of coronary plaque morphology on the precision of computational fractional flow reserve derived from optical coherence tomography imaging.

Authors:  Xiaoling Zeng; Emil Nielsen Holck; Jelmer Westra; Fukang Hu; Jiayue Huang; Hiroki Emori; Takashi Kubo; William Wijns; Lianglong Chen; Shengxian Tu
Journal:  Cardiovasc Diagn Ther       Date:  2022-04

Review 2.  The Role of Coronary Physiology in Contemporary Percutaneous Coronary Interventions.

Authors:  Federico Marin; Roberto Scarsini; Dimitrios Terentes-Printzios; Rafail A Kotronias; Flavio Ribichini; Adrian P Banning; Giovanni Luigi De Maria
Journal:  Curr Cardiol Rev       Date:  2022

3.  The association between provider characteristics and post-catheterization interventions.

Authors:  Adam C Powell; Jason P Goldstein; James W Long; Jeffrey D Simmons; Anthony DeFrance
Journal:  PLoS One       Date:  2022-04-01       Impact factor: 3.240

4.  Deceleration Capacity Improves Prognostic Accuracy of Relative Increase and Final Coronary Physiology in Patients With Non-ST-Elevation Acute Coronary Syndrome.

Authors:  Jun Wang; Chengzhe Liu; Fuding Guo; Zhen Zhou; Liping Zhou; Yueyi Wang; Huaqiang Chen; Huixin Zhou; Zhihao Liu; Shoupeng Duan; Ji Sun; Qiang Deng; Saiting Xu; Hong Jiang; Lilei Yu
Journal:  Front Cardiovasc Med       Date:  2022-03-22

5.  Case Report: Invasive and Non-invasive Hemodynamic Assessment of Coronary Artery Disease: Strengths and Weaknesses.

Authors:  Ganesh Gajanan; Saurabhi Samant; Chad Hovseth; Yiannis S Chatzizisis
Journal:  Front Cardiovasc Med       Date:  2022-04-25

6.  Impact of physiologically diffuse versus focal pattern of coronary disease on quantitative flow reserve diagnostic accuracy.

Authors:  Roberto Scarsini; Simone Fezzi; Gabriele Pesarini; Paolo Alberto Del Sole; Gabriele Venturi; Concetta Mammone; Michele Marcoli; Alessia Gambaro; Domenico Tavella; Michele Pighi; Flavio Ribichini
Journal:  Catheter Cardiovasc Interv       Date:  2021-11-10       Impact factor: 2.585

7.  Comparison Between 5- and 1-Year Outcomes Using Cutoff Values of Pressure Drop Coefficient and Fractional Flow Reserve for Diagnosing Coronary Artery Diseases.

Authors:  Rupak K Banerjee; Sruthi Ramadurai; Shreyash M Manegaonkar; Marepalli B Rao; Sathyaprabha Rakkimuthu; Mohamed A Effat
Journal:  Front Physiol       Date:  2021-07-14       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.